1. Home
  2. ACAD vs KTB Comparison

ACAD vs KTB Comparison

Compare ACAD & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$25.71

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo Kontoor Brands Inc.

KTB

Kontoor Brands Inc.

HOLD

Current Price

$57.23

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACAD
KTB
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ACAD
KTB
Price
$25.71
$57.23
Analyst Decision
Buy
Strong Buy
Analyst Count
22
8
Target Price
$30.00
$95.75
AVG Volume (30 Days)
1.2M
735.9K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
3.60%
EPS Growth
98.53
N/A
EPS
1.54
3.88
Revenue
$1,047,118,000.00
$2,833,659,000.00
Revenue This Year
$15.16
$20.46
Revenue Next Year
$11.79
$10.92
P/E Ratio
$17.00
$15.17
Revenue Growth
12.69
9.91
52 Week Low
$13.40
$50.00
52 Week High
$28.35
$96.80

Technical Indicators

Market Signals
Indicator
ACAD
KTB
Relative Strength Index (RSI) 43.17 35.95
Support Level $25.25 $56.91
Resistance Level $27.22 $59.35
Average True Range (ATR) 0.95 2.14
MACD -0.13 0.21
Stochastic Oscillator 18.16 16.19

Price Performance

Historical Comparison
ACAD
KTB

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: